Surgin

Endologix develops and manufactures minimally invasive treatments for vascular diseases. The company, working with leading practitioners to develop technology solutions for life-threatening medical conditions, is engaged in the development, manufacture, sales and marketing of minimally invasive therapies for the treatment of aortic aneurysms. Once an aneurysm develops, it continues to enlarge and if left untreated becomes increasingly susceptible to rupture. It is the cause of death for more than 15,000 people each year in the United States. Endologix's patented Powerlink System is a unibody self-expandable device with a durable frame made of stainless steel alloy covered with an expanded polytetrafluoroethylene graft. The one-piece bifurcated design featuring a fully supported stent cage was developed to overcome the many shortcomings associated with earlier-generation endoluminal graft devices. Endologix is headquartered in Irvine, Calif.

Sechrist Industries, based in Anaheim, CA, is a world leader in hyperbaric and respiratory medicine, offering high-quality technology solutions to the healthcare community since 1973. With a team of dedicated professionals, Sechrist identifies and fulfills healthcare opportunities to improve patient care, enhance practitioner convenience and efficiency, and provide cost-effective technology applications. Their hyperbaric chambers and respiratory products are built with unmatched experience and expertise, and their commitment to quality-driven values has established them as a recognized presence in the industry. Sechrist Industries is known for their innovative and comfortable Sechrist 3300HM Hyperbaric Chamber, which redefines hyperbaric therapy with its state-of-the-art design and patient accessibility features. Their eHEAL Hyperbaric Electronic Automated Logging System offers advanced recordkeeping and treatment logging software for clinicians. In addition, Sechrist provides a range of technical and field services, respiratory products, and general transport stretchers. With their hyperbaric chambers present in over 172 countries, Sechrist Industries continues to lead the hyperbaric therapy market, investing in research, development, and public awareness to support the hyperbaric oxygen therapy community.Generated from the website